We are on winter holidays

Both autologous and allogeneic serum eye drops show positive effects in patients with severe ocular surface diseases. But what are the differences between these forms of therapy?

Innovation runs in our blood 🩸 Our entire team will be taking a winter break from December 24 to January 6, 2026, to recharge our batteries. This will enable us to start the new year with lots of fresh ideas. We wish all our customers and business partners a relaxing holiday season and a happy New Year.

We’re back from an inspiring week at ISBT Milan 2025, where we had the opportunity to connect with leading voices in transfusion medicine from around the world.

Autologous serum eye drops are obtained from the patient's own blood and represent an individualized and highly effective form of treatment for patients with severe eye conditions.

Serum Eye Drops (SED) are highly effective in the treatment of patients suffering from dry eye disease, among other things. You can find out where and how to obtain serum eye drops in Austria here.

On point medicals has won the 2024 Innovations- and Research Award of the Federal State of Carinthia.

Dry eye disease (DED) is a prevalent and often underestimated ocular condition that affects millions of people worldwide. Find out more about causes, symptoms and treatment options.

Serum Eye Drops (SED) are similar to normal tears and show a high efficacy in therapy with patients suffering from severe ocular surface problems, such as Dry Eye Disease. Learn more about this widely unknown blood-derived therapy.

Blood irradiation is vital for patients at risk of developing TA-GvHD. Find out more about how to correctly verify blood irradiation and why dosimetry checks and the use of irradiation indicators should not be ignored or confused.

Blood irradiation is vital for patients at risk of developing TA-GvHD. Find out more about how to correctly verify blood irradiation and why dosimetry checks and the use of irradiation indicators should not be ignored or confused.